Therapeutic Potential of a Biodynamic Supplement on Skin Pressure Ulcers: A Randomized Clinical Study

Pressure ulcers (PUs) are a debilitating and often painful condition. They are localized lesions on the skin and/or underlying tissues and are common in the elderly, people with mobility difficulties, diabetics, and vascular disease or malnutrition, as well as in those requiring intensive or palliat...

Full description

Saved in:
Bibliographic Details
Published in:Biomedicines 2024-08, Vol.12 (8), p.1918
Main Authors: Ferorelli, Pasquale, Doepp, Manfred, Lenzi, Stefano, Rovelli, Roberto, Gisonna, Gennaro, Maierà, Giuseppe, Antonelli, Francesco, Radaelli, Massimo, Shevchenko, Anna, Feriotto, Giordana, Mischiati, Carlo, Borromeo, Ilaria, Beninati, Simone
Format: Article
Language:English
Subjects:
Bedsores
biodynamic therapy
Carbohydrates
Care and treatment
Consent
Dietary supplements
Enzymes
Lactase
Leg ulcers
Malnutrition
Medical nutrition therapy
Medical personnel
Medical research
Metabolism
Nutrition
nutritional supplement
Patients
Photographic equipment & supplies
Pressure ulcers
Skin
Skin diseases
Testing
Ulcers
Vascular diseases
Vitamins
Wound healing
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Pressure ulcers (PUs) are a debilitating and often painful condition. They are localized lesions on the skin and/or underlying tissues and are common in the elderly, people with mobility difficulties, diabetics, and vascular disease or malnutrition, as well as in those requiring intensive or palliative care. The prevention and treatment of PUs involve strategies to optimize hydration, circulation, and nutrition. Nutrition plays a key role in pressure ulcer care because wounds require macronutrients and micronutrients to heal. Reports relating to the effectiveness of "Complementary Enzyme Therapy" also in the vulnological field led us to this study, the aim of which was to test the activity of a biodynamic food supplement (Citozym ) rich in carbohydrates, vitamins, and amylase and lactase and characterized by marked antioxidant activity. Citozym administered topically and/or systemically, and in particular in both administrations, in patients suffering from Pus, has shown a marked reduction in bedsores and, in many cases, complete healing. Furthermore, it was possible to observe a lower incidence of side effects compared to conventional therapies. The results obtained, confirmed by various tests and recognized by the scientific community, allow us to conclude that treatment with Citozym could represent a new and effective strategy for the treatment of PUs.
ISSN:2227-9059
2227-9059
DOI:10.3390/biomedicines12081918